-
FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management
-
Youth E-cigarette Use Remains Serious Public Health Concern Amid COVID-19 Pandemic
-
Heart Health Supplements Market to Reach $29,000 Mn by 2026
-
US Prescription Drug Spending to Hit $400 Billion a Year by 2020: IMS Report
Trending Now
Drug Therapy for Osteoporosis in Older Adults
FDA approves drug for adults with rare form of bone marrow disorder
FDA alerts health care professionals of potential risks associated with compounded ketamine nasal spray
New Medicaid Option Promotes Enhanced Mental Health, Substance Use Crisis Care
U.S. Surgeon General Issues Advisory on Youth Mental Health Crisis Further Exposed by COVID-19 Pandemic
Various Treatments Yield Sustained Reductions in Body Weight, Blood Pressure
FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other Drugs
Featured Stories
Pharmacy News Today's Monthly Awards
